E-test method for testing susceptibilities of Aspergillus spp. to the new triazoles voriconazole and posaconazole and to established antifungal agents:: Comparison with NCCLS broth microdilution method

被引:73
作者
Espinel-Ingroff, A
Rezusta, A
机构
[1] Virginia Commonwealth Univ, Med Coll Virginia, Med Mycol Res Lab, Div Infect Dis, Richmond, VA 23298 USA
[2] Fac Huesca, Zaragoza, Spain
关键词
D O I
10.1128/JCM.40.6.2101-2107.2002
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
NCCLS document M38-P describes standard parameters for testing the fungistatic activities (MICs) of established agents against filamentous fungi (molds). This study evaluated the in vitro susceptibilities of 15 Aspergillus flavus isolates, 62 A. fumigatus isolates, and 10 isolates each of A. niger, A. nidulans, and A. terreus to voriconazole, posaconazole, itraconazole, and amphotericin B by the E-test and NCCLS M38-P microdilution methods. The agreement (within 3 dilutions) between methods for voriconazole was independent of the E-test incubation time (93.3 to 100% for four of five species at both incubation times). In contrast, with amphotericin B, itraconazole, and posaconazole, E-test results were more dependent on the incubation time for certain species. For A. fumigatus, posaconazole E-test MICs had better concordance with reference values after 48 h (95.2%) than after 24 h (90%), while the highest agreement for itraconazole MICs was after 24 h (90.3 versus 74.2%) of incubation. Better agreement between the methods was also obtained with 24-h E-test amphotericin B MICs for A.flavus (73.3 versus 26.7%) and A.fumigatus (96.7 versus 64.5%). E-test MICs of the four agents had the lowest percentages of agreement with reference values for A. nidulans (60 to 80%). For isolates for which high MICs were obtained for the four agents by the reference method, high MICs were also obtained by E-test at both 24 and 48 h. The utility of in vitro results of either the E-test or the NCCLS broth microdilution (M38-P) method for Aspergillus spp. needs to be established in clinical trials.
引用
收藏
页码:2101 / 2107
页数:7
相关论文
共 28 条
  • [1] Quality control limits for broth microdilution susceptibility tests of ten antifungal agents
    Barry, AL
    Pfaller, MA
    Brown, SD
    Espinel-Ingroff, A
    Ghannoum, MA
    Knapp, C
    Rennie, RP
    Rex, JH
    Rinaldi, MG
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (09) : 3457 - 3459
  • [2] Chumpitazi BFF, 2000, J CLIN MICROBIOL, V38, P438
  • [3] Correlation between in vitro susceptibility determined by E test and response to therapy with amphotericin B: Results from a multicenter prospective study of candidemia
    Clancy, CJ
    Nguyen, MH
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (05) : 1289 - 1290
  • [4] Itraconazole resistance in Aspergillus fumigatus
    Denning, DW
    Venkateswarlu, K
    Oakley, KL
    Anderson, MJ
    Manning, NJ
    Stevens, DA
    Warnock, DW
    Kelly, SL
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (06) : 1364 - 1368
  • [5] Optimal susceptibility testing conditions for detection of azole resistance in Aspergillus spp.:: NCCLS collaborative evaluation
    Espinel-Ingroff, A
    Bartlett, M
    Chaturvedi, V
    Ghannoum, M
    Hazen, KC
    Pfaller, MA
    Rinaldi, M
    Walsh, TJ
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (06) : 1828 - 1835
  • [6] Comparison of the E-test with the NCCLS M38-P method for antifungal susceptibility testing of common and emerging pathogenic filamentous fungi
    Espinel-Ingroff, A
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (04) : 1360 - 1367
  • [7] Comparison of in vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts
    Espinel-Ingroff, A
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (10) : 2950 - 2956
  • [8] COMPARATIVE AND COLLABORATIVE EVALUATION OF STANDARDIZATION OF ANTIFUNGAL SUSCEPTIBILITY TESTING FOR FILAMENTOUS FUNGI
    ESPINELINGROFF, A
    DAWSON, K
    PFALLER, M
    ANAISSIE, E
    BRESLIN, B
    DIXON, D
    FOTHERGILL, A
    PAETZNICK, V
    PETER, J
    RINALDI, M
    WALSH, T
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (02) : 314 - 319
  • [9] Interlaboratory evaluation of Etest method for testing antifungal susceptibilities of pathogenic yeasts to five antifungal agents by using Casitone agar and solidified RPMI 1640 medium with 2% glucose
    EspinelIngroff, A
    Pfaller, M
    Erwin, ME
    Jones, RN
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (04) : 848 - 852
  • [10] Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi
    EspinelIngroff, A
    Bartlett, M
    Bowden, R
    Chin, NX
    Cooper, C
    Fothergill, A
    McGinnis, MR
    Menezes, P
    Messer, SA
    Nelson, PW
    Odds, FC
    Pasarell, L
    Peter, J
    Pfaller, MA
    Rex, JH
    Rinaldi, MG
    Shankland, GS
    Walsh, TJ
    Weitzman, I
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (01) : 139 - 143